STTK
Shattuck Labs, Inc.
$4.58
-4.58%
$368.1M
No data for this timeframe.
Vol
Market Cap$368.1M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (86%)
Inst. Holders7 funds
Inst. Value$17.1M
Inst. Activity2 buys / 0 sells
Insider Activity0B / 2S
Insider Net $-$212.5K
SEC Reports7
Press Releases1
Recent Activity
Jun 5, 2026
routine
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
<p align="left">AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, I
Jun 2, 2026
SEC
Shattuck Labs held its 2026 Annual Meeting on May 28, 2026. Stockholders approved an amendment and restatement of the 20
8-K — Impact 3/10
May 29, 2026
Insider
Ashiya Mona sold 81,000 shares
Director @ $0.00 ($0.00)
May 29, 2026
Insider
SIEGALL CLAY B sold 81,000 shares
Director @ $0.00 ($0.00)
May 29, 2026
Insider
Golumbeski George sold 81,000 shares
Director @ $0.00 ($0.00)
May 18, 2026
SEC
Two STTK insiders (CMO and CTO) sold a combined $212K in open-market sales on May 12, 2026, following the Q1 earnings re
CLUSTER — Impact 3/10
May 15, 2026
SEC
Two senior executives at Shattuck Labs (CMO and CTO) sold a combined $212K in open-market shares on May 12, 2026, one we
CLUSTER — Impact 3/10
Inst.
FMR LLC — DOUBLED
392,600 shares ($1.4M)
Price Targets
$12.50
+172.9% upside
Strong Buy
Current $4.58
Low $7.00
Median $12.50
High $18.00
6 analysts
$7.00
$18.00
Analyst Ratings
3Strong Buy
9Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 5, 2026 | Citigroup | UPGRADE | Neutral → Buy |
| May 8, 2026 | Wedbush | MAINTAIN | Outperform → Outperform |
| Apr 27, 2026 | Cantor Fitzgerald | INITIATE | Overweight |
| Apr 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Mar 13, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.14 ▼ -8.8% | $-0.18 — $-0.09 | 43% YoY | 6 |
| Next Q | $-0.13 ▼ -5.9% | $-0.21 — $-0.08 | 8% YoY | 6 |
| Current FY | $-0.46 ▲ +9.2% | $-0.58 — $-0.38 | 34% YoY | 5 |
| Next FY | $-0.51 ▼ -7.1% | $-0.88 — $-0.34 | -11% YoY | 6 |
Latest Reports
NEUTRAL
8-K
3/10
Shattuck Labs held its 2026 Annual Meeting on May 28, 2026. Stockholders approved an amendment and restatement of the 20
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
Two STTK insiders (CMO and CTO) sold a combined $212K in open-market sales on May 12, 2026, following the Q1 earnings re
May 18, 2026
NEUTRAL
Press
5/10
Shattuck Labs reported financial results for Q4 and full year 2025, showing reduced net losses and R&D expenses due to p
Mar 5, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $8.7M | — |
| BANK OF AMERICA CORP | $4.0M | DOUBLED |
| TWO SIGMA INVESTMENTS, LP | $1.6M | DOUBLED |
| FMR LLC | $1.4M | DOUBLED |
| RENAISSANCE TECHNOLOGIES LLC | $1.2M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 29, 2026 | Ashiya Mona | A | $0.00 |
| May 29, 2026 | SIEGALL CLAY | A | $0.00 |
| May 29, 2026 | Golumbeski George | A | $0.00 |
| May 29, 2026 | Gibson Neil | A | $0.00 |
| May 29, 2026 | Baker Daniel | A | $0.00 |
7 institutional holders with $17.1M total value (4,694,381 shares) as of 2025-Q4. Top holders: VANGUARD, BANK, TWO. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 2,377,746 | $8.7M | 50.7% | — |
| 2 | BANK OF AMERICA CORP /DE/ | 1,106,617 | $4.0M | 23.6% | DOUBLED +2968.2% |
| 3 | TWO SIGMA INVESTMENTS, LP | 437,729 | $1.6M | 9.3% | DOUBLED +431.1% |
| 4 | FMR LLC | 392,600 | $1.4M | 8.4% | DOUBLED +11560.2% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | 340,700 | $1.2M | 7.3% | ADD +57.1% |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 20,881 | $76.2K | 0.4% | NEAR_EXIT -81.7% |
| 7 | MORGAN STANLEY | 18,108 | $66.1K | 0.4% | TRIM -30.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | DOUBLED | 3,367 | 392,600 | +11560.2% | $1.4M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 216,867 | 340,700 | +57.1% | $1.2M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 36,891 | 1,131,888 | +2968.2% | $2.7M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 76,934 | 408,598 | +431.1% | $976.5K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 38,100 | 216,867 | +469.2% | $518.3K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 24,088 | 16,651 | -30.9% | $39.8K | 2025-Q3 |
| FMR LLC | TRIM | 8,438 | 3,367 | -60.1% | $8.0K | 2025-Q3 |
| UBS Group AG | NEAR_EXIT | 268,371 | 1,433 | -99.5% | $3.4K | 2025-Q3 |
| UBS Group AG | ADD | 151,150 | 268,371 | +77.6% | $212.5K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 28,000 | 38,100 | +36.1% | $30.2K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 99,803 | 36,891 | -63.0% | $29.2K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 80,379 | 24,088 | -70.0% | $19.1K | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEAR_EXIT | 114,139 | 20,906 | -81.7% | $16.6K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | 20,267 | 851 | -95.8% | $674.00 | 2025-Q2 |
| UBS Group AG | ADD | 114,352 | 151,150 | +32.2% | $143.6K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 130,679 | 85,238 | -34.8% | $81.0K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 277,930 | 80,379 | -71.1% | $76.4K | 2025-Q1 |
| FMR LLC | ADD | 6,279 | 10,216 | +62.7% | $9.7K | 2025-Q1 |
| UBS Group AG | TRIM | 224,766 | 114,352 | -49.1% | $138.4K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 250,600 | 28,100 | -88.8% | $34.0K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 13,999 | 19,822 | +41.6% | $24.0K | 2024-Q4 |
| CITADEL ADVISORS LLC | EXIT | 176,842 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | ADD | 219,793 | 277,609 | +26.3% | $968.9K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 114,139 | — | $398.3K | 2024-Q3 |
11 unique insiders with 2 transactions. Net insider value: -$212.5K ($0.00 bought, $212.5K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | Ashiya Mona | Director | A | 81,000 | $0.00 | $0.00 |
| May 29, 2026 | SIEGALL CLAY B | Director | A | 81,000 | $0.00 | $0.00 |
| May 29, 2026 | Golumbeski George | Director | A | 81,000 | $0.00 | $0.00 |
| May 29, 2026 | Gibson Neil W | Director | A | 81,000 | $0.00 | $0.00 |
| May 29, 2026 | Baker Daniel G. | Director | A | 81,000 | $0.00 | $0.00 |
| May 29, 2026 | Boudreau Helen M | Director | A | 81,000 | $0.00 | $0.00 |
| May 22, 2026 | SIEGALL CLAY B | Director | M | 128,054 | $0.00 | $0.00 |
| May 22, 2026 | SIEGALL CLAY B | Director | A | 128,054 | $1.08 | $138.9K |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | M | 5,122 | $0.00 | $0.00 |
| May 21, 2026 | Shukla Abhinav A. | Chief Technical Officer | A | 5,122 | $1.08 | $5.6K |
| May 15, 2026 | Stout Stephen | See Remarks | A | 12,805 | $1.08 | $13.9K |
| May 15, 2026 | Stout Stephen | See Remarks | M | 12,805 | $0.00 | $0.00 |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer | A | 25,610 | $1.08 | $27.8K |
| May 12, 2026 | Schreiber Taylor | Chief Executive Officer | M | 25,610 | $0.00 | $0.00 |
| May 12, 2026 | Pandite Arundathy N. | Chief Medical Officer | SELL | 30,000 | $6.61 | $198.3K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | M | 2,032 | $3.57 | $7.3K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | SELL | 2,032 | $7.01 | $14.2K |
| May 12, 2026 | Shukla Abhinav A. | Chief Technical Officer | M | 2,032 | $0.00 | $0.00 |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | A | 64,027 | $1.08 | $69.4K |
| May 12, 2026 | Neill Andrew R | Chief Financial Officer | M | 64,027 | $0.00 | $0.00 |
| May 10, 2026 | Stout Stephen | See Remarks | F | 968 | $6.85 | $6.6K |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 6 neutral. Avg impact: 3.6/10.
NEUTRAL
8-K
3/10
Shattuck Labs held its 2026 Annual Meeting on May 28, 2026. Stockholders approved an amendment and r
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
Two STTK insiders (CMO and CTO) sold a combined $212K in open-market sales on May 12, 2026, followin
May 18, 2026
NEUTRAL
CLUSTER
3/10
Two senior executives at Shattuck Labs (CMO and CTO) sold a combined $212K in open-market shares on
May 15, 2026
NEUTRAL
8-K
3/10
Shattuck Labs reported Q1 2026 net loss of $0.13 per share, slightly better than consensus of -$0.14
May 7, 2026
BULLISH
PRESS-RELEASE
5/10
Shattuck Labs reported Q1 2026 EPS of -$0.12, beating consensus of -$0.13 by 9.1%, with zero revenue
May 7, 2026
NEUTRAL
DEFA14A
3/10
Shattuck Labs is holding its annual shareholder meeting to vote on director elections, auditor ratif
Apr 8, 2026
NEUTRAL
8-K
5/10
Shattuck Labs reported full-year 2025 financial results showing reduced net loss of $48.8 million (d
Mar 5, 2026
Current analyst consensus: Strong Buy (86% buy). Based on 14 analysts: 3 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$12.50 mean target
+172.9% upside
Strong Buy (3.00)
$7.00 Low
$18.00 High
| Metric | Value |
|---|---|
| Current Price | $4.58 |
| Target Low | $7.00 |
| Target Mean | $12.50 |
| Target Median | $12.50 |
| Target High | $18.00 |
| # Analysts | 6 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.14 | $-0.18 | $-0.09 | 42.9% | -8.8% | 1↑ 1↓ | $0.0B | 0.0% | 6 |
| Next Q 2026-09-30 |
$-0.13 | $-0.21 | $-0.08 | 7.7% | -5.9% | 1↑ 1↓ | $0.0B | -100.0% | 6 |
| Current FY 2026-12-31 |
$-0.46 | $-0.58 | $-0.38 | 33.9% | +9.2% | 0↑ 3↓ | $0.0B | -100.0% | 5 |
| Next FY 2027-12-31 |
$-0.51 | $-0.88 | $-0.34 | -10.6% | -7.1% | 0↑ 1↓ | $0.0B | 0.0% | 6 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.137 | |
| 7d ago | $-0.137 | |
| 30d ago | $-0.126 | -0.011 |
| 60d ago | $-0.128 | -0.009 |
| 90d ago | $-0.128 | -0.009 |
5 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 2 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 5, 2026 | Citigroup | UPGRADE | Neutral | Buy |
| May 8, 2026 | Wedbush | MAINTAIN | Outperform | Outperform |
| Apr 27, 2026 | Cantor Fitzgerald | INITIATE | — | Overweight |
| Apr 20, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Mar 13, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Mar 6, 2026 | Wedbush | MAINTAIN | Outperform | Outperform |
| Jan 28, 2026 | Piper Sandler | INITIATE | — | Overweight |
| Jan 6, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| May 1, 2026 | 3 | 9 | 2 | 0 | 0 | 86% | |
| Apr 1, 2026 | 3 | 8 | 2 | 0 | 0 | 85% | |
| Mar 1, 2026 | 3 | 7 | 3 | 0 | 0 | 77% | |
| Feb 1, 2026 | 3 | 7 | 3 | 0 | 0 | 77% | |
| Jan 1, 2026 | 3 | 6 | 3 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 5, 2026
routine
Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8
<p align="left">AUSTIN, Texas and DURHAM, N.C., June 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage bi
May 13, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-05-13
May 7, 2026
earnings
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
<p align="justify">AUSTIN, Texas and DURHAM, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a
May 4, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-05-04
Apr 29, 2026
earnings_calendar
STTK Q1 2026 Earnings Scheduled — 2026-04-29
Mar 17, 2026
earnings_calendar
STTK Q4 2025 Earnings After Market Close — 2026-03-17
Mar 5, 2026
earnings
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
<p align="justify">AUSTIN, Texas and DURHAM, N.C., March 05, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK),